L01FF01 - nivolumab (Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors)
L01FY02 - nivolumab + relatlimab (Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Combinations of monoclonal antibodies and antibody drug conjugates)